✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Albert David Ltd.

ALBERTDAVD

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹466 Cr.
P/E
74.08

Albert David Ltd.

  • Albert David
  • Brooks Laboratories
  • Medicamen Biotech
  • TJI Pharma - Small Cap
FAQs on Albert David Ltd. Shareprice

Albert David has given lower returns compared to its competitors.
Albert David has grown at ~5.8% over the last 7yrs while peers have grown at a median rate of 12.52%

Albert David is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Albert David is 73.37, while 3 year average PE is 12.16.
Also latest EV/EBITDA of Albert David is 0.0 while 3yr average is 20.12.

View FAQ's On Business
Growth Table
  • Albert David Ltd.
  • Brooks Laboratories
  • Medicamen Biotech
Balance Sheet
  • Albert David Ltd.
  • Brooks Laboratories
  • Medicamen Biotech
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Albert David Ltd.
  • Brooks Laboratories
  • Medicamen Biotech
Cash Flow
  • Albert David Ltd.
  • Brooks Laboratories
  • Medicamen Biotech
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Albert David Ltd.
  • Brooks Laboratories
  • Medicamen Biotech
Quarterly Results
  • Albert David Ltd.
  • Brooks Laboratories
  • Medicamen Biotech
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Albert David Ltd. Financials

Balance sheet of Albert David is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Albert David is increasing.
Latest debt of Albert David is ₹6.69 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹60.2 Crs.

No, profit is decreasing.
The profit of Albert David is ₹6.29 Crs for TTM, ₹17.2 Crs for Mar 2025 and ₹75.42 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Albert David latest dividend payout ratio is 16.59% and 3yr average dividend payout ratio is 13.16%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech